We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
1051
DELISTED
Amicus Therapeutics
FOLD
$5K ﹤0.01%
490
NBP
1052
NovaBridge Biosciences American Depositary Shares
NBP
$206M
$5K ﹤0.01%
63
+26
+70% +$1.72K
OPK icon
1053
Opko Health
OPK
$936M
$5K ﹤0.01%
1,260
PCRX icon
1054
Pacira BioSciences
PCRX
$1.04B
$5K ﹤0.01%
82
PRTA icon
1055
Prothena Corp
PRTA
$455M
$5K ﹤0.01%
88
RCKT icon
1056
Rocket Pharmaceuticals
RCKT
$355M
$5K ﹤0.01%
120
RVMD icon
1057
Revolution Medicines
RVMD
$40B
$5K ﹤0.01%
143
VCYT icon
1058
Veracyte
VCYT
$4.44B
$5K ﹤0.01%
133
NSTG
1059
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
83
DRNA
1060
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5K ﹤0.01%
141
ALXO icon
1061
ALX Oncology
ALXO
$272M
$4K ﹤0.01%
79
BLUE
1062
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
10
CSTL icon
1063
Castle Biosciences
CSTL
$741M
$4K ﹤0.01%
48
GMAB icon
1064
Genmab
GMAB
$17.7B
$4K ﹤0.01%
86
GRFS
1065
Grifois
GRFS
$5.27B
$4K ﹤0.01%
224
HCM icon
1066
HUTCHMED
HCM
$1.91B
$4K ﹤0.01%
97
IGMS
1067
DELISTED
IGM Biosciences
IGMS
$4K ﹤0.01%
46
INO icon
1068
Inovio Pharmaceuticals
INO
$79.4M
$4K ﹤0.01%
34
IRWD icon
1069
Ironwood Pharmaceuticals
IRWD
$644M
$4K ﹤0.01%
301
LGND icon
1070
Ligand Pharmaceuticals
LGND
$5.96B
$4K ﹤0.01%
53
MCRB icon
1071
Seres Therapeutics
MCRB
$47M
$4K ﹤0.01%
9
MYGN icon
1072
Myriad Genetics
MYGN
$515M
$4K ﹤0.01%
141
PTGX icon
1073
Protagonist Therapeutics
PTGX
$8.72B
$4K ﹤0.01%
81
XNCR icon
1074
Xencor
XNCR
$1.47B
$4K ﹤0.01%
108
ZNTL icon
1075
Zentalis Pharmaceuticals
ZNTL
$321M
$4K ﹤0.01%
76

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.